Clinical Trial Update: Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial studying ONC206 (JZP3507) in adults with advanced pheochromocytoma and paraganglioma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraganglioma
• Pheochromocytoma

Drugs mentioned

• ONC206 (ONC206)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Advanced Pheochromocytoma and Paraganglioma, PCPG | Phase 2 | Status: RECRUITING